FDA could authorize boosters for 16- and 17-year-olds, improving fight against COVID-19
The FDA is considering whether to authorize boosters for 16- and 17-year-olds and could announce a decision as soon as Thursday. It comes as U.S. health officials are urging Americans to use all the tools available to fight COVID-19. Nikki Battiste reports.